Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 87,074	$ 56,573
Prepaid expenses	600,000
Total Current Assets	687,074	56,573
Deferred offering costs		309,175
Marketable securities held in Trust Account	230,014,425
TOTAL ASSETS	230,701,499	365,748
Current liabilities
Accrued expenses	5,776,435	4,119
Accrued offering costs		185,880
Promissory note – related party	200,000	155,000
Total Current Liabilities	5,976,435	344,999
Deferred underwriting fee payable	7,568,750
Warrant liabilities	14,480,000
Total Liabilities	28,025,185	344,999
Commitments and Contingencies
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; 23,000,000 and no shares subject to possible redemption at redemption value at December 31, 2021 and 2020, respectively	230,000,000
Stockholders’ (Deficit) Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding at December 31, 2021 and 2020	575	575
Additional paid-in capital		24,425
Accumulated deficit	(27,324,261)	(4,251)
Total Stockholders’ (Deficit) Equity	(27,323,686)	20,749
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	$ 230,701,499	$ 365,748